No reduction in the sufentanil requirement of elderly patients undergoing ventilatory support in the medical intensive care unit

European Journal of Anaesthesiology

Volumn 16, Issue 10, 1999, Pages 702-707

  Hofbauer, R ^b   Tesinsky, P ^b   Hammerschmidt, V ^b   Kofler, J ^b   Staudinger, T ^b   Kordova, H ^b   Vrastiolova, M ^b   Frass, M ^b   Freye, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

Intensive care unit: sufentanil, elderly patients, tachyphylaxis, withdrawal like syndrome

Indexed keywords

MIDAZOLAM; SUFENTANIL;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PROSPECTIVE STUDY; SEDATION; SIDE EFFECT; TACHYPHYLAXIS; WITHDRAWAL SYNDROME;

AGED; AGING; ANALGESICS, OPIOID; CONSCIOUS SEDATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDAZOLAM; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SUFENTANIL; TACHYPHYLAXIS;

EID: 0032695260     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.1999.00569.x     Document Type: Article

References (26)

1. Ball M, McQuay HJ, Moore RA, Allen MC, Fischer A, Sear J. Renal failure and the use of morphine in the intensive care. Lancet 1987; 1: 784-786.
2. Monk JP, Beresford R, Ward A. Sufentanil. A review of its pharmacological properties and therapeutic use. Drugs 1988; 36: 286-313.
3. Helmers JH, van Leuwen L, Zuurmond WW. Sufentanil pharmacokinetics in young adult and elderly surgical patients. Eur J Anaesthesiol 1994; 11: 181-185.
4. Wappler F, Scholz J, Prause A, Möllenberg O, Bause H. Schulte am Esch J. Stufenkonzept zur Analgosedierung in der Intensivmedizin mit Sufentanil. Anästhesiol Intensivmed Notfallmed Schmerzther 1998; 33: 18-26.
5. Niemegeers CJE, Schellenkens KHL, van Bever WFM, Janssen PAJ. Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs. Arzneimittelforsch 1976; 216: 1551-1556.
6. Scott JG, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effects: Comparative pharmaco-dynamics of fentanyl and sufentanil. Anesthesiology 1991; 74: 34-42.
7. Smith NT, Westover CJ, Qinn M, Benthuysen L, Silver DH, Sanford TJ. An electroencephalographic comparison of alfentanil with other narcotics and with thiopental. J Clin Monit 1985; 1: 236-244.
8. Kröll W, List WF. Eignet sich Sufentanil für die Langzeitanalgosedierung kritischer Kranker? Anaesthesist 1992; 41: 271-275.
9. Hughes MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76: 334-341.
10. Matteo RS, Schwartz AE, Ornstein E, Young WL, Cang W. Pharmacokinetics of sufentanil in the elderly surgical patient. Can J Anaesth 1990; 73: 240-243.
11. Greenblatt DJ, Sellers EM, Shader IJ. Drug disposition in the old age. N Engl J Med 1982; 306: 1081-1088.
12. Helmers JH, van Peer A, Noorduin H, Woestenborghs R, vanden Busche G, Heykants J. Sufentanil kinetics in the elderly. Beitr Anästhesiol Intensivmed 1987; 20: 376-377.
13. Leaf A. Medicine in the aged. N Engl J Med 1977; 297: 887-890.
14. Ramsey MAE, Savage TM, Simpson BNRJ, Goodwin R. Controlled sedation with alphaloxone-alphadone. Br Med J 1974; II: 656-659.
15. Goris RJA, Nuytinck HKS, Redl H. Scoring systems and predictors of ARDS and MOF. In: Schlag G, Redl H, eds. Progress in Clinical and Biological Research First Vienna Shock Forum. New York: Alan R Liss, 1987: 236B: 3-15.
16. Pesau B, Falger S, Berger E, Weiman J, Schuster E, Leithner C, Frass M. Influence of age on outcome of mechanically ventilated patients in an intensive care unit. Crit Care Med 1992; 20: 489-492.
17. Pacher R, Redl H, Frass M, Petzl DH, Schuster E, Woloszczuk W. Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med 1989; 17: 221-226.
18. Bailey PL, Streisand JB, East KA et al. Differences in magnitude and duration of opioid induced respiratory depression and analgesia with fentanyl and sufentanil. Anesth Analg 1990; 70: 8-15.
19. Arunasalam K, Davenport HT, Painter S, Jones JG. Ventilalory response to morphine in young and old subjects. Anaesthesia 1983; 38: 529-533.
20. Bellville JW, Forrest WJ, Miller E, Brown BW. Influence of age on pain relief from analgesics. JAMA 1971; 217: 1835-1841.
21. Kaiko RF. Age and morphine analgesia in cancer patients with postoperative pain. Clin Pharmacol Ther 1980; 18: 823-826.
22. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240: 159-166.
23. Freye E, Arndt JO. Perfusion of the fourth cerebral ventricle with fentanyl induces naloxone reversible hypotension, bradycardia, baroreflex depression and sleep in unanaesthetized dogs. Naunyn-Schmiedebergs Arch Pharmacol 1979; 307: 123-128.
24. Coyle JT, Pert CB. Ontogenetic development of (3H)-naloxone binding in rat brain. Neuropharmacology 1976; 15: 555-560.
25. Singelton MA, Rosen JI, Fischer DM. Pharmacokinetics of fentanyl in the elderly. Br J Anaesth 1988; 60: 619-622.
26. Gold MS, Pottash AC, Sweeney DR, Kleber HD. Opiate withdrawal using clonidin. A safe, effective, and rapid nonopiate treatment. JAMA 1980; 243: 343-348.